![UAB Med Cast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/02/8a/87/028a87d0-e184-5d05-5fcf-c6227e819f5a/mza_7429392662585331696.png/100x100bb.jpg)
Diagnosis and Management of Progressive Pulmonary Fibrosis (PPF)
UAB Med Cast
English - June 12, 2023 07:00 - 10.8 MB - ★★★★★ - 15 ratingsHealth & Fitness uab medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Fibrotic lung disease is a group of around 200 entities that have inflammation and/or fibrosis in common. The “progressive” phenotype of pulmonary fibrosis has recently become more well-defined. Tejaswini Kulkarni, M.D., explains the characteristics of progressive pulmonary fibrosis (PPF). She discusses the importance of recognizing when interstitial lung disease is indeed PPF and addressing it with a combination of immunosuppressive and antifibrotic therapies. Learn about the advantages of interdisciplinary care for patients with PPF, including early recognition and management of worsening lung function; use of pulmonary rehabilitation and supplemental oxygen for better quality of life; and walking patients through the lung transplant process when necessary.